EMA — authorised 7 January 2021
- Marketing authorisation holder: AERIE PHARMACEUTICALS IRELAND LIMITED
- Status: approved
EMA authorised Xalatan on 7 January 2021
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 7 January 2021.
AERIE PHARMACEUTICALS IRELAND LIMITED holds the EU marketing authorisation.